<DOC>
	<DOCNO>NCT00008086</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Calcitriol may help solid tumor cell develop normal cell . Combining calcitriol chemotherapy may kill tumor cell . PURPOSE : Phase I trial study effectiveness calcitriol combine carboplatin treating patient advance solid tumor .</brief_summary>
	<brief_title>Calcitriol Plus Carboplatin Treating Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum tolerated dos calcitriol carboplatin , give combination , patient advance solid tumor . - Determine toxic effect regimen patient . - Determine effect calcitriol pharmacokinetics carboplatin patient . - Correlate pharmacokinetics carboplatin myelosuppression follow regimen patient . - Determine safety efficacy regimen patient malignant glioma . OUTLINE : This dose-escalation study . Patients stratify accord disease ( brain tumor v solid tumor ) accrue parallel . Patients assign one two treatment group . - Group 1 : Patients receive carboplatin IV 20-30 minute day 1 calcitriol subcutaneously ( SC ) orally daily day 2-4 first course . For subsequent course , patient receive calcitriol SC orally daily day 1-3 carboplatin IV 20-30 minute day 3 . - Group 2 : Patients receive calcitriol SC orally daily day 1-3 carboplatin IV 20-30 minute day 3 first , third , subsequent course . For second course , patient receive carboplatin IV 20-30 minute day 1 calcitriol SC orally daily day 2-4 . In group , treatment repeat every 28 day absence disease progression unacceptable toxicity . Sequential dose escalation calcitriol follow sequential dose escalation carboplatin . Cohorts 3-6 patient receive escalate dos calcitriol carboplatin maximum tolerate dose ( MTD ) combination determine . The MTD define dose precede 2 6 patient experience dose-limiting toxicity . PROJECTED ACCRUAL : Approximately 18-50 patient accrue study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm advanced solid tumor curable standard therapy , include glioma brain tumor Brain metastasis allow follow definitive radiotherapy PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 8 week Hematopoietic : Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 1.5 mg/dL SGOT great 4 time normal Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 60 mL/min Creatinine great 2.0 mg/dL Calcium great 10.5 mg/dL Cardiovascular : No unstable angina No symptomatic coronary artery disease Other : Not pregnant nursing Negative pregnancy test Fertile patient must use 2 form barrier contraception AND 1 form hormonal contraception least 1 week , , least 2 week study No active infection No concurrent serious condition PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior biologic therapy ( regional systemic ) Chemotherapy : At least 4 week since prior chemotherapy Endocrine therapy : No concurrent glucocorticoid antiemetic Concurrent exogenous glucocorticoid allow treatment glioma brain tumor Radiotherapy : See Disease Characteristics At least 4 week since prior radiotherapy Surgery : Not specify Other : Dietary calcium intake 200250 mg/day begin 48 hour course continue 7 day No concurrent dairy product , green leafy vegetable , molasses , bake powder , fortify cereal , dry pea bean</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult craniopharyngioma</keyword>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult meningioma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult central nervous system germ cell tumor</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult pineocytoma</keyword>
	<keyword>adult pineoblastoma</keyword>
	<keyword>adult meningeal hemangiopericytoma</keyword>
	<keyword>adult choroid plexus tumor</keyword>
	<keyword>adult grade III meningioma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>